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Background: Hepatitis E virus (HEV) has been reported in the human population and pigs are a recognized
reservoir for HEV and a possible source of HEV transmission to humans. Spray-dried porcine plasma (SDPP) is an
ingredient commonly used in feed for pigs around the world. Even though processing conditions used to produce
SDPP should be adequate to inactivate HEV, it was of interest to analyze commercial SDPP samples for presence of
genome and antibodies (AB) against HEV and to retrospectively analyze serum samples collected from pigs used in
past experiments that had been fed diets containing either 0% or 8% SDPP to detect potential transmission of HEV
as determined by seroconversion.
Results: Eighty-five commercial SDPP samples were analyzed by ELISA and 100% of them contained AB against
HEV, while 22.4% (11 of 49 samples analyzed) were positive for HEV RNA.
Frozen sera samples (n = 140) collected from 70 pigs used in past experiments that had been fed diets containing
either 0% or 8% commercial SDPP was analyzed by ELISA for AB against HEV. Age of pigs at sera sampling ranged
from 3 to 15 weeks and feeding duration of diets ranged from approximately 4 to 9 weeks. One lot of SDPP used
in one experiment was analyzed and confirmed to contain HEV RNA. Regardless of the diet fed, some sera samples
collected at the beginning of an experiment contained AB titer against HEV. These sera samples were collected
from weaned pigs prior to feeding of the experimental diets and the HEV titer was probably from maternal origin.
However, by the end of the experiments, HEV titer was not detected or had declined by more than 50% of the
initial titer concentration.
Conclusions: To our knowledge, this is the first study reporting presence of HEV AB titer and RNA in SDPP.
Retrospective analysis of serum collected from pigs fed diets with SDPP revealed no indication of seroconversion
to HEV. The results indicate that feeding SDPP in diets for pigs does not represent a risk of transmitting HEV,
even though HEV genome may be detected in SDPP.
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Antecedentes: El virus de la Hepatitis E (HEV) se ha descrito en la población humana y se reconoce a los cerdos
como reservorio para el HEV y como posible fuente de transmisión en humanos. El plasma porcino atomizado
(SDPP) es un ingrediente comúnmente utilizado en dietas para cerdos a nivel mundial. Aunque el proceso de
producción utilizado para el SDPP debería ser suficiente para inactivar el HEV, podría ser de interés analizar
muestras comerciales de SDPP para detectar la presencia de material genético y anticuerpos (AB) frente a HEV y
retrospectivamente analizar muestras de suero recogidas de cerdos utilizados en estudios anteriores que fueron
alimentados con dietas conteniendo tanto 0% o 8% de SDPP para detectar mediante seroconversión la posible
transmisión de HEV.
Resultados: Ochenta y ocho muestras comerciales de SDPP fueron analizadas por ELISA y el 100% de ellas
contenían AB frente a HEV, mientras que un 22,4% (11 de 49 muestras analizada) eran positivas para ARN de HEV.
Muestras de suero congeladas (n = 140) recogidas de 70 cerdos utilizados en experimentos anteriores que habían
consumido dietas conteniendo tanto un 0% o un 8% SDPP comercial fueron analizadas por ELISA para AB frente a
HEV. La edad de los cerdos en el momento del muestreo era de entre 3 a 15 semanas y la duración de las dietas
fue desde aproximadamente 4 a 9 semanas. Un lote de SDPP utilizado en uno de los experimentos fue analizado y
confirmado de contener ARN de HEV. Independientemente de las dietas suministradas, algunas muestras de suero
contenían títulos de AB frente a HEV al comienzo de los experimentos. Estas muestras de suero fueron recogidas en
lechones antes de ser alimentados con las dietas experimentales por lo que los títulos frente a HEV probablemente
se debieran a origen materno. Sin embargo, al final de los experimentos, el título frente a HEV o bien no se detectó
o se redujo en más de un 50% respecto a la titulación inicial.
Conclusión: Hasta nuestro conocimiento, este es el primer estudio que reporta la presencia de títulos de AB y ARN
de HEV en SDPP. Análisis retrospectivo de suero recogido de lechones alimentados con dietas con SDPP revelaron
la no seroconversión frente HEV. Los resultados indican que alimentando SDPP en dietas para cerdos no representa
un riesgo de transmitir HEV, incluso si el genoma de HEV pudiera estar presente en SDPP.Background
Spray-dried porcine plasma (SDPP) as an ingredient in diets
for nursery pigs is well recognized to improve growth rate,
feed intake, feed efficiency, and to reduce post-weaning
diarrhea, mortality, and morbidity [1,2]. In addition, weaned
pigs fed diets supplemented with SDPP had reduced
intestinal inflammation, mucosal barrier dysfunction,
and diarrhea [3].
In recent years, sporadic cases of Hepatitis E virus
(HEV) have been reported in the human population of
the USA, Europe, and developed countries of the
Asian-Pacific region and this virus is now considered
an emerging disease [4]. Pigs are recognized as a po-
tential reservoir for HEV [5,6] and as a possible source
of HEV transmission to humans [7-9]. The main trans-
mission route for HEV is fecal-oral [10]. The virus has been
identified on swine farms in many geographical areas, in-
cluding the USA and Europe, and the reported prevalence
ranges from 22% to 55% [10,11].
Hepatitis E virus is a non-enveloped positive-sense
single-stranded RNA virus that is 27–34 nm in diameter
and has been classified in the Hepeviridae family, genus
Hepevirus [10]. Currently four distinct genotypes distrib-
uted geographically are described. Genotypes 1 and 2
HEV are restricted to humans whereas only genotypes 3
and 4 have been recovered from pigs, humans and
others species and are responsible for sporadic cases ofHEV in humans. Genotype 3 is found predominantly in
Europe, North America and South America [12-14].
Hepatitis E virus is low to moderately resistant to heat
and is almost completely inactivated after 1 h of incuba-
tion at 60°C to 66°C for all strains tested [15].
Data collected in different European countries show
prevalence in weaner pigs ranging from 8% to 30%, be-
tween 20% and 44% in growers and 8% to 73% in fat-
teners [16]. Similarly, the prevalence of HEV in Spain
has been reported to range from 20% to 59% and was
widely distributed in nearly 100% of investigated swine
farms [17-19]. Therefore, prevalence of HEV is high in
all age groups of pigs, including pigs at slaughter age,
which could still be infected with HEV.
The objectives of the study were to analyze the presence
of HEV RNA and antibodies (AB) in commercial samples
of SDPP obtained from a Spanish manufacturer and to
retrospectively analyze serum samples collected from pigs
used in past studies that were fed diets containing 8%
SDPP to determine any potential risk of transmission of
HEV as indicated by seroconversion in those animals.Results
Presence of AB and HEV RNA in SDPP
All eighty-five commercial SDPP samples (100%) con-
tained detectable AB against HEV (Figure 1). Eleven of
Table 1 Antibody titers against HEV in retained serum
samples collected from pigs fed diets with or without
spray dried porcine plasma1
SDPP 2 Pig ID Day 0 Day 45
0% 28 Neg Neg
0% 1000 Neg Neg
0% 1027 Neg Neg
0% 1049 0.752 Neg
0% 1050 1.188 Neg
8% 27 Neg Neg
8% 999 Neg Neg
8% 1026 Neg Neg
8% 1047 1.302 Neg
8% 1048 1.139 Neg
8% 6964 Neg Neg
1Optical density values analyzed by ELISA. Neg means that the O.D. value is
below the cut-off established for the technique (<0.300).
2Serum collected from pigs weaned at 3 to 4 wks of age and fed diets with
either 0% or 8% SDPP for 45 days [33]. Serum samples from pigs were stored
at −80°C since the experiment was completed (April to October 2006) and
retrospectively analyzed for the presence of HEV AB during April to May 2012.
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positive to HEV genome.
Retrospective HEV titer analysis of sera samples collected
from pigs fed diets containing SDPP
Serum samples (n = 72) from 36 pigs (initial age, 6 weeks)
used in an experiment in which pigs were fed diets con-
taining either 0% SDPP (n = 18) or 8% SDPP (n = 18) for
9 weeks was retrospectively analyzed for HEV AB by
ELISA. HEV titers were not detected in any serum sam-
ples that were collected at day 0 or day 63 of this
experiment.
Retrospective HEV titer analysis of a separate set of
sera samples (n = 22) collected from 11 pigs (initial
age, 3 to 4 weeks) fed diets containing either 0% SDPP
(n = 5) or 8% SDPP (n = 6) for 45 days are presented in
Table 1. HEV titer was detected in sera from 4 pigs
(2 in each group) at the beginning of the experiment;
however by the end of the experiment, no HEV titer
was detected in any of the samples. Sera samples at
the beginning of the experiment were collected prior
to feeding experimental diets, so it is probable that the
titer detected was of maternal origin. Absence of titer
in all sera samples collected at the end of the experi-
ment indicates there was no seroconversion to HEV.
Results of HEV titer analysis of a third set of sera sam-
ples (n = 46) from 23 pigs (initial age, 3.5 weeks) fed di-
ets with 0% SDPP (n = 12) or 8% SDPP (n = 11) for
28 days are presented in Table 2 . Pigs in this experiment
were divided into four groups, with two groups chal-
lenged with porcine reproductive and respiratory syn-
drome virus (PRRSV) and fed diets with either 0% SDPP
(n = 6) or 8% SDPP (n = 5) or two groups not challenged
with PRRSV and fed diets with either 0% SDPP (n = 6)
or 8% SDPP (n = 6). HEV titer was detected in serum
collected at the beginning of the experiment from 4 pigsFigure 1 Antibodies against HEV in 81 different samples of
commercial spray-dried porcine plasma batches produced from
November 2009 to December 2010. The established cut-off
optical density value was 0.300 for positive detection of antibodies.
Each bullet point indicates a Positive (spheres), Negative (triangles)
or Unrealized (diamonds) RT-PCR results.(1 pig from each of the 4 groups). By the end of the
study (28 days later) only 1 sample that previously con-
tained HEV titer (probably from maternal origin) still
had HEV AB, although at a much lower titer (Table 2).
The SDPP used in this study was positive for the pres-
ence of HEV genome analyzed by nested RT-PCR. The
HEV titer results indicate there was no seroconversion,
even though the SDPP used in the study contained HEV
RNA. Presence of viral genome as determined by PCR
does not determine if the genome is capable of causing
infection.
Discussion
These studies constitute the first survey about the pres-
ence of AB against HEV and HEV genome in SDPP. The
results indicated that 100% of commercial SDPP samples
collected during a 13 month-period contained AB
against HEV and 22.4% of samples contained HEV RNA.
These results are consistent with the reported HEV AB
prevalence of 50% to 100% of pigs at the end of fattening
period [17,20], and that 91.5% to 97.6% of farms had pigs
with HEV antibodies [19,21]. Likewise, 13.9% of serum
samples from pigs older than 6 months were found posi-
tive for HEV RNA in a recent Spanish serological survey
of 85 farms [18]. Serological studies reported a world-
wide distribution of HEV in swine herds located in the
USA, New Zealand, Mexico, Japan and European coun-
tries [10]. This high percentage of HEV sero-positive
SDPP obtained in our study is not surprising, as liquid
plasma from approximately 30,000 to 40,000 pigs is
pooled to produce a batch of commercial SDPP. Spray
dried plasma has previously been shown to contain AB
Table 2 Antibodies titers against HEV in serum samples
from pigs fed diets containing spray dried porcine
plasma and challenged with PRRSV1,2
SDPP Group3 PRRSV Challenge4 Pig ID Day 0 Day 28
8% Yes 37 Neg Neg
8% Yes 40 1.011 0.446
8% Yes 59 Neg Neg
8% Yes 63 Neg Neg
8% Yes 64 Neg Neg
0% Yes 41 Neg Neg
0% Yes 44 Neg Neg
0% Yes 46 Neg Neg
0% Yes 47 Neg Neg
0% Yes 48 0.586 Neg
0% Yes 57 Neg Neg
8% No 68 Neg Neg
8% No 70 Neg Neg
8% No 72 0.429 Neg
8% No 75 Neg Neg
8% No 78 Neg Neg
8% No 79 Neg Neg
0% No 84 Neg Neg
0% No 87 Neg Neg
0% No 88 Neg Neg
0% No 97 0.317 Neg
0% No 98 Neg Neg
0% No 99 Neg Neg
1Optical density values analyzed by ELISA. Neg means that the O.D. value is
below the cut-off established for the technique (<0.300).
2Serum samples from pigs were stored at −80°C since the experiment [34] was
completed (April to October, 2006) and retrospectively analyzed for the
presence of HEV AB during April to May, 2012.
3Respective control or SDPP groups of pigs were fed diets containing 0% or
8% SDPP for 28 days.
4Indicated if the pigs were intranasal challenged with PRRSV.
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tion at any point in time [22]. The presence of AB
against HEV in SDPP may have potential to provide pas-
sive immunity at the gut mucosal level while being fed
to post-weaning pigs. Recent research has demonstrated
that liquid porcine plasma contains antibodies against
porcine circovirus type 2 (PCV-2) and that after spray
drying neutralizing activity was conserved [23].
Under natural conditions, the dynamics of HEV infec-
tion is similar to that described for other viral infections
in pigs. Acquisition of passive immunity through colos-
trum absorption (60% of pigs), progressive decline of
passive AB at 6 to 12 wk of age, then seroconversion be-
tween 14 to 17 wk of age, which is the peak of viremia
[10], is followed by a gradual decline to slaughter age
[20]. However, this pattern can differ depending on strainof HEV. At Japanese swine farms infected with two com-
mon genotype III HEV strains, peak HEV fecal excretion
was observed between 1 to 3 mo of age (75% to 100% of
the pigs) and by 5 to 6 mo of age, it had declined to 7% of
the pigs [24].
Blood is not a primary reservoir of HEV, which is
mainly present in liver, stomach, small intestine, spleen,
kidneys, salivary glands, tonsils and lungs [10]. However,
in Japan it was reported that 10% of pigs at 3 mo of age
had HEV in their blood (32/310 positives) but none of
the 136 pigs tested positive at 6 mo of age [25]. Similar
observations have been reported in a Spanish surveil-
lance study of 6 farrow-to-finish swine herds positive for
HEV. Although viremia was observed in some animals
at 13 wks of age in one of the herds, none of the pigs at
slaughter age from any herd contained HEV in their
blood [26]. However, it is possible that pigs with low
protective immunity can acquire an HEV infection dur-
ing their productive life [27] and may contain HEV RNA
in blood at slaughter age [26] and as demonstrated in
our current analysis of SDPP collected from a Spanish
plasma plant. Therefore, although presence of HEV in
blood of pigs at slaughter age is low, it is important to
demonstrate the absence of HEV transmission risk from
feeding pigs diets containing SDPP that may contain
HEV RNA.
Heat resistance of HEV is not very high. In cell cul-
tures, HEV was inactivated at 56°C within 30 min or at
66°C during 1 h, depending on virus strain [15,28].
Complete inactivation of HEV in pig liver or in complex
meat matrices was achieved at an internal temperature
of 71°C [29,30].
Several studies conducted with laboratory spray-driers
have demonstrated that the processing conditions used
in the plasma industry inactivate low to medium heat re-
sistant viruses like porcine pseudorabies virus (PRV) and
PRRSV [31] and even high heat resistant viruses like
swine vesicular disease (SVDV) virus [32]. Two recent
studies also confirmed that porcine epidemic diarrhea
virus (PEDV) was effectively inactivated in plasma by
spray drying in a lab drier [33,34]. In addition, several
studies have demonstrated that commercial SDPP in di-
ets fed to pigs does not transmit heat resistant viruses
such as PCV2 or PPV [31,35-37].
There are numerous features used in the manufactur-
ing process of commercial SDPP that contribute to the
bio-safety of this functional protein ingredient. Only
blood from healthy pigs that have passed ante-mortem
inspection by veterinary competent authorities and ap-
proved as fit for slaughter for human consumption is
collected for commercially produced SDPP. Avoidance
of collecting plasma from clinically affected pigs de-
creases the risk of potential pathogen transmission; how-
ever, in case of asymptomatic diseases like HEV, the
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should assure inactivation of such pathogens that cannot
be detected at inspection. Other safety features, in
addition of the pooling effect mentioned earlier includes
spray-drying at high processing temperatures.
Spray drying is the transformation of a feed from a
fluid state into a dried particulate by spraying the
feed into a gaseous drying medium. The spray-drying
process can be divided into 3 significant steps, includ-
ing atomization of the liquid feed, interaction of the
liquid droplet with the drying gases, and separation of
the dried powder from the drying gases [38,39]. The
conditions in each step can affect the physical charac-
teristics of the powder and microbial survival [39].
The spray drying process used in commercial manufac-
turing of SDPP has demonstrated its efficacy as a
pasteurization-like process to inactivate bacteria and
viruses [35] as indicated above. The spray-drying
process submits liquid plasma to a thermal process
of > 80°C throughout its substance. Therefore, the heat
treatment used during the spray-drying process is the-
oretically adequate to inactivate HEV if present in the
raw material. In addition, numerous pathogens do not
survive well in a dehydrated substance like SDPP
(moisture < 9% and water activity <0.6) that is stored in
dry environment for at least 2 weeks prior to release
for sale. Furthermore, the inherent neutralizing anti-
bodies in pooled liquid plasma can be regarded as an
additional effective safety feature of the manufacturing
process for SDPP [23,36]. Recent evidence indicates
that neutralizing antibody activity is maintained even
after plasma is spray-dried [23]. All these different
safety features of the manufacturing process for SDPP
(healthy animals, dilution factor, spray-drying process,
dry environment, storage at room temperature for at
least two weeks and inherent neutralizing antibodies)
collectively contribute to the safety of SDPP as a feed
ingredient as demonstrated for a variety of swine path-
ogens previously studied [31,33-37].
Results from our retrospective analysis of serum sam-
ples collected from pigs fed commercial SDPP in 3
different experiments indicated absence of HEV virus
transmission by feeding diets with SDPP, as observed by
the lack of HEV seroconversion. In the results reported
in Table 2, HEV seroconversion was not detected even
though pigs were experimentally infected with PRRSV,
which may make pigs potentially more susceptible to
other infections due to the immune depression charac-
teristics of PRRSV infection. A sample of the SDPP used
in the diets associated with the experiment reported in
Table 2 was PCR positive for HEV RNA; however, no
HEV seroconversion was determined in the serum sam-
ples of pigs fed the diets with this SDPP lot even though
some of these pigs were immune compromised due toPRRSV challenge. Samples of SDPP used in the other ex-
periments were not available, so it was not possible to
determine if these samples contained either HEV RNA
or titer. However a retrospective serological study con-
ducted in Spain showed that endemic HEV infection in
pigs had been present in the Spanish swine population
since at least 1985 [17]. Therefore, it can be speculated
that the commercial Spanish SDPP used in the experi-
ments likely contained HEV titer and/or RNA. Never-
theless, it should be highlighted that the presence of
viral genome analyzed by RT-PCR in SDPP does not
indicate infectivity, because this technique is unable to
distinguish between infectious and non-infectious virus
particles [35,40]. Consequently, the potential infectiveness
of SDPP cannot be established by RT-PCR results and
studies like the ones reported in this document are needed
to determine infectivity potential of viral genome.
Conclusions
HEV antibodies were detected in 100% of the SDPP sam-
ples collected from a Spanish manufacturing plant and
22.4% of these samples also contained HEV RNA, indicat-
ing the high prevalence of HEV in the Spanish pig popula-
tion. In addition, 70 sera samples from 35 pigs from 3 to
15 weeks of age at the beginning of been fed diets contain-
ing 8% SDPP for 4 to 9 weeks did not demonstrate sero-
conversion to HEV. According to the conditions used in
this study, the results indicated that feeding SDPP in diets
for pigs does not represent a risk of transmitting HEV.
Materials and methods
Analytical techniques
HEV enzyme linked inmuno-assay (ELISA)
IgG antibodies to HEV in diluted SDPP samples (9% w/v
in distilled water) or serum samples collected from pigs
fed diets with SDPP in three separate experiments were
analyzed using an in-house developed ELISA assay [41].
Briefly, polystyrene plates with 96 wells (Costar 3590)
were coated overnight at 4°C with a purified open
reading frame 2 truncated protein; HEV-ORF2-6His, the
main virus capsid protein from porcine genotype 3 F
strain. Samples were added at a dilution of 1:100. To
detect pig antibodies to HEV a conjugated HRP anti-
porcine IgG secondary antibody was used and TMB was
used as a chromogen. Readings were done at 450 nm. A
negative and a positive control serum were also analyzed
at dilutions of 1:50, 1:100, 1:200, and 1:400. Cut-off was
0.300 O.D. and was determined using four times the SD
calculated for control serum.
Hepatitis E virus by semi-nested reverse transcription-PCR
(RT-PCR)
Viral RNA from diluted SDPP samples was extracted
using the Nucleospin® RNA virus kit (Macherey-Nagel
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turer’s recommendations. Hepatitis E virus RNA was de-
tected according to a semi-nested RT-PCR developed by
De Deus et al. [12].Sample collection procedures and storage
Presence of AB and HEV RNA in SDPP
Eighty-five spray-dried porcine plasma samples from
a Spanish company were collected from 81 different
manufacturing batches produced from November 2009
through December 2010. Dried samples were diluted in
PBS at a ratio of 1:9 before being analyzed for presence
of total AB against HEV by ELISA as previously described.
Forty-nine of these samples were selected at random and
analyzed for HEV RNA as previously described.Presence of AB in serum samples
Serum samples (n = 72) collected from 36 pigs at 6 and
15 weeks of age that were fed diets with either 0% SDPP
(n = 18 pigs) or 8% SDPP (n = 18 pigs) for 9 weeks [31]
were retrospectively investigated for the presence of AB
against HEV by ELISA. Briefly, these pigs were weaned
at 4 wks of age and fed a common diet for 2 wks and
determined to be negative for antibodies against PRV,
PRRSV and PPV. Subsequently, pigs were allotted to six
pens with six pigs per pen and fed diets containing
either 0 or 8% SDPP (18 pigs and 3 pens per diet) for 9
wks. Blood samples had been collected from pigs at the
beginning and end of the 9 week feeding period to deter-
mine whether feeding SDPP caused seroconversion and
development of AB against PPV, PRRSV, or PRV.
The blood sampling was conducted from April 4 to
June 26, 2000 and HEV analysis was performed from
April 4 to May 30, 2012. Serum samples had been main-
tained at −20°C since the study; however a sample of the
SDPP used in the feed had not been retained. Since sero-
conversion was not detected then PCR analysis was not
done.
Serum samples collected from pigs used in a study
published by Pujols et al. [35] were retrospectively inves-
tigated for the presence of AB against HEV by ELISA.
Briefly, the study was conducted to determine whether
feeding diets with SDPP containing 2.47 x 105 DNA cop-
ies of porcine circovirus type 2 (PCV2) could infect
weanling pigs. The two groups of pigs were housed in
separate bio-safety level-3 rooms. None of the pigs in
either group developed any clinical signs or became
PCV2 viraemic or seroconverted.
The blood sampling was conducted from October 9 to
December 4, 2006 and the HEV analysis was performed
from April 19 to May 30, 2012. Serum samples had been
maintained at −80°C since the study. Due to the lack of
retrospectively available samples of the SDPP used in thefeed (AP820P lot # Y617932) it was not possible to
analyze the SDPP for presence of HEV genome.
A third set of serum samples (n = 46) collected from
23 pigs (initial age, 3.5 wks) fed diets containing either
0% SDPP (n = 12 pigs) or 8% SDPP (n = 11 pigs) for 4
wks [36] were retrospectively analyzed for the presence
of AB against HEV by ELISA. Briefly, the objective of
the experiment was to evaluate if SDPP containing
PCV2 genome supplemented in feed could transmit
PCV2 to pigs challenged with PRRSV. Twenty-three
PRRSV-free pigs at 25 d of age, were housed in bio-
safety level 3 facilities and assigned to four groups in a
2x2 factorial design consisting of pigs subjected or not
to PRRSV challenge and fed the diets containing either
0% SDPP or 8% SDPP. Challenge groups were inocu-
lated intra-nasally with 2 mL of a suspension contain-
ing 106 TCID50 PRRSV/mL. Drinking water for pigs
fed the diet with 8% SDPP was supplemented from
day −4 to day 7 post-inoculation with spray dried porcine
serum (SDPS) to deliver a final solution of 2% w/v. Dietary
treatments were fed for 28 d post-inoculation (PI). All
challenged pigs developed PRRSV viraemia by d 3 PI and
PRRSV AB were detected in sera by d 14 PI, with no dif-
ference between dietary treatments. Neither PRRSV vir-
aemia nor seroconversion was detected in non-challenged
pigs. Porcine circovirus type 2 DNA was not detected in
the serum of any pigs throughout the experimental period.
Spray dried porcine plasma containing the PCV2 genome
supplemented in feed did not result in PCV2 transmission
to either healthy or PRRSV-infected pigs under these ex-
perimental conditions.
The blood sampling was conducted from March 16 to
April 16, 2009 and HEV analysis was performed from
April 19 to May 30, 2012. A sample of SDPP used in the
feed and serum samples had been maintained at −80°C
until analyzed for the presence of RNA HEV genome
and AB against HEV.Abbreviations
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